Migami, Inc. Continues Implementation of Acquisition Strategy Regarding Various Proprietary Drug-Delivery Platforms and Manufacturing Facilities
4/3/2009 8:55:02 AM
WOODLAND HILLS, Calif.--(BUSINESS WIRE)--Migami, Inc. (symbol: MIGA), a pharmaceutical and cosmeceutical company located in Woodland Hills, CA, (“Migami”) is negotiating a Letter of Intent (“LOI”) regarding an Asset Purchase for certain GMP manufacturing assets. The LOI being negotiated contemplates the purchase of a 90,000-square feet, state-of-the-art manufacturing facility in Arizona and other related assets.
comments powered by